Estrogen Plus Progestin and Colorectal Cancer Incidence and Mortality

PURPOSE: During the intervention phase in the Women's Health Initiative (WHI) clinical trial, use of estrogen plus progestin reduced the colorectal cancer diagnosis rate, but the cancers were found at a substantially higher stage. To assess the clinical relevance of the findings, analyses of th...

Full description

Saved in:
Bibliographic Details
Main Authors: Simon, Michael S., Chlebowski, Rowan T., Wactawski-Wende, Jean, Johnson, Karen C., Muskovitz, Andrew, Kato, Ikuko, Young, Alicia, Hubbell, F. Allan, Prentice, Ross L.
Format: Artigo
Language:Inglês
Published: American Society of Clinical Oncology 2012
Subjects:
Original Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488271/
https://ncbi.nlm.nih.gov/pubmed/23008295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.7732
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items